We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Guideline on Handling Endobronchial Ultrasound Transbronchial Needle Samples

By MedImaging International staff writers
Posted on 21 Oct 2024
Print article
Image: CHEST has released a new clinical guideline on endobronchial ultrasound-guided transbronchial needle aspiration specimen processing and handling (Photo courtesy of CHEST)
Image: CHEST has released a new clinical guideline on endobronchial ultrasound-guided transbronchial needle aspiration specimen processing and handling (Photo courtesy of CHEST)

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has become the standard procedure for the initial diagnosis and staging of lung cancer; however, there is limited guidance on how to handle and process specimens during and after acquisition to enhance both diagnostic yield and specimen preservation for subsequent ancillary testing. Given the significant variation in sample collection practices among different institutions, a new clinical guideline on EBUS-TBNA now aims to utilize the experiences of both pulmonologists and pathologists to standardize the process.

The strength of evidence regarding the handling and processing of EBUS-TBNA specimens varies, but there is sufficient information in some areas to assist clinicians with specific aspects of specimen handling. The American College of Chest Physicians (CHEST, Glenview, IL, USA) has published a new clinical guideline on EBUS-TBNA, which strongly recommends performing four or more needle passes instead of three or fewer in patients suspected of having malignant disease undergoing EBUS-TBNA. The guideline also advises utilizing rapid on-site evaluation rather than standard care for patients with suspected malignancies undergoing EBUS-TBNA. Furthermore, for patients suspected of having malignant disease, the guideline recommends using a smaller needle (21 gauge or 22 gauge) instead of a larger one (19 gauge). The complete list of recommendations outlined in the new guideline can be accessed through the CHEST journal website.

Related Links:
CHEST

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Portable X-ray Unit
AJEX130HN
New
Mini C-arm Imaging System
Fluoroscan InSight FD
Opaque X-Ray Mobile Lead Barrier
2594M

Print article

Channels

MRI

view channel
Image: MRI microscopy of mouse and human pancreas with respective histology demonstrating ability of DTI maps to identify pre-malignant lesions (Photo courtesy of Bilreiro C, et al. Investigative Radiology, 2024)

Pioneering MRI Technique Detects Pre-Malignant Pancreatic Lesions for The First Time

Pancreatic cancer is the leading cause of cancer-related fatalities. When the disease is localized, the five-year survival rate is 44%, but once it has spread, the rate drops to around 3%.... Read more

General/Advanced Imaging

view channel
Image: The results of the eight-view 3D CT reconstruction from a public dataset (Photo courtesy of Medical Physics, doi.org/10.1002/mp.12345)

AI Model Reconstructs Sparse-View 3D CT Scan With Much Lower X-Ray Dose

While 3D CT scans provide detailed images of internal structures, the 1,000 to 2,000 X-rays captured from different angles during scanning can increase cancer risk, especially for vulnerable patients.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.